10 Merck finance leaders
Merck's finance bench runs from the company's CFO and its Global Controller and Corporate Treasurer down to finance heads for Human Health, Merck Research Laboratories, manufacturing and a Durham plant. A finance leader setting up R&D budgeting, a manufacturing cost model or treasury for a drug company will find someone here whose title matches that exact seat.
Professionals to explore
Brandon Jones
LinkedInExperience: Director of Finance, Durham Plant Controller · Merck
$336 per 30-minute call
Director of Finance, Durham Plant Controller at Merck since May 2021, Brandon Jones came to the role with Finance Manager at Amazon (2020-2021) and Genentech roles including Senior Finance Manager, Technical Operations (2019-2020) and Senior Finance Manager, Business Partner and Global Controller (2017-2019). Plant-level cost and controllership questions are the natural fit.
Is this you? Claim your profile and get paid for calls.
Caroline Litchfield
LinkedInExperience: Chief Financial Officer · Merck
$3,029 per 30-minute call
Caroline Litchfield has been Chief Financial Officer at Merck since April 2021, serving as executive vice president and CFO responsible for finance, procurement and real estate. At Merck the record also includes Senior Vice President & Treasurer (2019-2021), Senior Vice President Finance - Global Human Health (2014-2018), Finance Lead - Emerging Markets (2009-2013) and Head of Finance - Europe & Canada (2008-2009).
Is this you? Claim your profile and get paid for calls.
Dalton Smart, CPA, MBA
LinkedInExperience: Senior Vice President Finance, Global Controller · Merck
$1,346 per 30-minute call
Senior Vice President Finance, Global Controller at Merck since December 2023, Dalton Smart was Vice President, Assistant Controller (2023) and Vice President, Corporate Audit and Assurance Services (2015-2023) there. Executive Director, Audit roles at Merck (2009-2015) and Schering Pharmaceuticals (2008-2009) make this the strongest pick for questions on controllership and internal audit at a drugmaker.
Is this you? Claim your profile and get paid for calls.
James Hall
LinkedInExperience: CFO, GHH US Market · Merck
$673 per 30-minute call
James Hall holds two current Merck titles: CFO, GHH US Market since June 2015 and CFO, US Vaccines Market Global Vaccines Finance Lead. That combination of US market and vaccines finance titles suits questions about running finance for a single large market and for a vaccines portfolio.
Is this you? Claim your profile and get paid for calls.
John Carroll
LinkedInExperience: Vice President Finance Merck Manufacturing · Merck
$673 per 30-minute call
For manufacturing finance, John Carroll has been Vice President Finance Merck Manufacturing since March 2015. Merck audit titles were Vice President, Merck Corporate Audit and Assurance Services (2009-2015) and VP Global Internal Audits (2006-2009), with Vice President & General Auditor at American Standard Brands (2002-2006) and a Bristol Myers Squibb stint (1990-2001) that includes VP & CFO - Tech Ops.
Is this you? Claim your profile and get paid for calls.
Melissa Leonard
LinkedInExperience: Senior Vice President, Corporate Treasurer · Merck
$1,346 per 30-minute call
As Senior Vice President, Corporate Treasurer at Merck since August 2024, Melissa Leonard also held Vice President, Manufacturing Finance (2021-2024) and Associate Vice President, Finance & Transition Management Lead - Organon Spin (2019-2021) at Merck. MSD titles include Associate Vice President, Finance Lead Europe & Canada (2014-2017) and Executive Director, Finance Lead UK & Ireland (2013-2014), a fit for treasury and spin-off finance questions.
Is this you? Claim your profile and get paid for calls.
Nicole Longo
LinkedInExperience: Senior Vice President, Finance, Merck Human Health · Merck
$1,346 per 30-minute call
Nicole Longo, Senior Vice President, Finance, Merck Human Health since January 2019, partners with Merck's Chief Operating Officer and Chief Marketing Officer on accurate financial reporting and compliance. Vice President, Finance roles for Merck Research Labs (2015-2018) and Merck Animal Health (2012-2014), plus Vice President, Financial Control, US Pharmaceutical Operations at Sanofi (1993-2009), cover commercial, research and animal health finance.
Is this you? Claim your profile and get paid for calls.
Phil Rinnander
LinkedInExperience: Former Executive Director, Financial Evaluation & Analysis · Merck
$673 per 30-minute call
Phil Rinnander is Executive Director, Vaccines Contracting & Distribution at Merck since December 2025, and also held Executive Director, Financial Evaluation & Analysis (2023-2026), Executive Director, Global Human Health US Finance Lead Customer Contract Management (2018-2023) and Director, Commercial Supply Chain Strategy and Access (2017-2018). VP and Commercial Finance Head at Anacor Pharmaceuticals (2016) adds a commercial finance role outside Merck.
Is this you? Claim your profile and get paid for calls.
Ruth Yuh-Ru Chen
LinkedInExperience: Finance Director · Merck
$404 per 30-minute call
All of Ruth Yuh-Ru Chen's roles are at Merck: Finance Director since June 2016, an earlier Finance Director stint (2014-2016), Financial Controller (2011-2014), Financial Planning Manager (2007-2011) and Associate Accounting Manager (2005-2007). Ruth's work covers statutory reporting and tax, a fit for those questions inside a global drug company.
Is this you? Claim your profile and get paid for calls.
Thomas Hall
LinkedInExperience: Senior Vice President · Merck
$841 per 30-minute call
Thomas Hall has been Senior Vice President at Merck since July 2024, a role their LinkedIn profile gives as Senior Vice President, Finance Merck Research Laboratories, and was Vice President, Finance Merck Research Laboratories (2021-2024). VP, Financial Planning & Analysis (2019-2021) and Associate Vice President, Financial Planning and Analysis, Corporate Financial Services (2016-2018) make this a good call on research budgeting and FP&A.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Caroline Litchfield, Dalton Smart and Melissa Leonard hold the corporate seats (CFO, controller, treasurer), so pick among them for questions about the center of the function. Nicole Longo, Thomas Hall and James Hall sit closer to the businesses and research, while John Carroll and Brandon Jones cover manufacturing and plant finance, Phil Rinnander suits contracting questions and Ruth Yuh-Ru Chen statutory reporting and tax.
Questions to take into the conversation
- 01How does a drug company's finance team decide how much R&D spend to commit to a program before late-stage data comes in?
- 02What does a plant controller at a pharmaceutical site report on, and how does it roll up to manufacturing finance?
- 03How did the finance team plan the separation of a spun-off business such as Organon while keeping reporting on track?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.